Biblio
2021
Bouvier A, Hamel J-F, Delaunay J, Delabesse E, Dumas P-Y, Ledoux MPierre, Peterlin P, Luquet I, Guepin GRoth, Bulabois CEric, et al. Molecular classification and prognosis in younger adults with acute myeloid leukemia patients and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: final results of the GOELAMS/FILO AML 2006-IR trial. Eur J Haematol. 2021.
2015
Pardanani A, Harrison C, Cortes JE, Cervantes F, Mesa RA, Milligan D, Masszi T, Mishchenko E, Jourdan E, Vannucchi AM, et al. Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial. JAMA Oncol. 2015.